Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/28441
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | MORAES-SILVA, Ivana C. | - |
dc.contributor.author | RODRIGUES, Bruno | - |
dc.contributor.author | COELHO-JUNIOR, Helio J. | - |
dc.contributor.author | FERIANI, Daniele Jardim | - |
dc.contributor.author | IRIGOYEN, Maria-Claudia | - |
dc.date.accessioned | 2018-09-13T15:28:18Z | - |
dc.date.available | 2018-09-13T15:28:18Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | EXERCISE FOR CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT: FROM MOLECULAR TO CLINICAL, PT 1, v.999, p.139-153, 2017 | - |
dc.identifier.isbn | 978-981-10-4307-9; 978-981-10-4306-2 | - |
dc.identifier.issn | 0065-2598 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/28441 | - |
dc.description.abstract | In 2016, cardiovascular disease remains the first cause of mortality worldwide [1]. Coronary artery disease, which is the most important precursor of myocardial infarction (MI), is the main component of total cardiovascular mortality, being responsible for approximately seven million of deaths [1]. In approximately 20% of infarcted patients, MI is recurrent in the first year after the event [2]. Moreover, among cardiovascular disease, coronary artery disease accounts for the most increased index of life years lost due to morbidity and/or mortality [1]. Sedentarism highly contributes to cardiovascular disease burden, especially for coronary artery disease, and is also one of the MI risk factors [3]. For many years, it was recommended to avoid physical activity after a cardiovascular event; nowadays, it is a consensus that exercise training (ET) should be part of cardiac rehabilitation programs. There is increasing evidence confirming that, when adequately prescribed and supervised, ET after MI can prevent future complications and increase the quality of life and longevity of infarcted patients [4, 5]. ET after MI follows international specialized guidelines; however, there are different protocols adopted by several societies worldwide in cardiac rehabilitation [6], and there is still lack of information on which type and regimen of exercise may be the ideal after MI, as well as how these exercises act to promote beneficial effects to cardiovascular and other organic systems. Thus, experimental studies are important contributors to elicit mechanisms behind clinical results, and to test and compare different ET protocols. Therefore, exercise prescription can be optimized, individualized, and safely practiced by patients. In this chapter, we present a brief review of MI pathophysiology followed by an updated discussion of the most relevant discoveries regarding ET and MI in basic science. | - |
dc.language.iso | eng | - |
dc.publisher | SPRINGER-VERLAG SINGAPORE PTE LTD | - |
dc.relation.ispartof | Exercise for Cardiovascular Disease Prevention and Treatment: from Molecular to Clinical, Pt 1 | - |
dc.relation.ispartofseries | Advances in Experimental Medicine and Biology | - |
dc.rights | restrictedAccess | - |
dc.subject | Myocardial infarction | - |
dc.subject | Exercise training | - |
dc.subject | Rehabilitation | - |
dc.subject | Coronary | - |
dc.subject.other | american-heart-association | - |
dc.subject.other | baroreflex sensitivity | - |
dc.subject.other | clinical-implications | - |
dc.subject.other | experimental-model | - |
dc.subject.other | autonomic function | - |
dc.subject.other | physical-activity | - |
dc.subject.other | oxidative stress | - |
dc.subject.other | diabetic-rats | - |
dc.subject.other | pathophysiology | - |
dc.subject.other | dysfunction | - |
dc.title | Myocardial Infarction and Exercise Training: Evidence from Basic Science | - |
dc.type | article | - |
dc.rights.holder | Copyright SPRINGER-VERLAG SINGAPORE PTE LTD | - |
dc.identifier.doi | 10.1007/978-981-10-4307-9_9 | - |
dc.identifier.pmid | 29022262 | - |
dc.subject.wos | Cardiac & Cardiovascular Systems | - |
dc.subject.wos | Medicine, Research & Experimental | - |
dc.subject.wos | Physiology | - |
dc.type.category | article; book chapter | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | RODRIGUES, Bruno:Univ Campinas UNICAMP, Fac Phys Educ, Campinas, SP, Brazil | - |
hcfmusp.author.external | COELHO-JUNIOR, Helio J.:Univ Campinas UNICAMP, Fac Phys Educ, Campinas, SP, Brazil | - |
hcfmusp.author.external | FERIANI, Daniele Jardim:Univ Campinas UNICAMP, Fac Phys Educ, Campinas, SP, Brazil | - |
hcfmusp.description.beginpage | 139 | - |
hcfmusp.description.endpage | 153 | - |
hcfmusp.description.volume | 999 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000438271500009 | - |
hcfmusp.origem.id | 2-s2.0-85031746420 | - |
hcfmusp.publisher.city | SINGAPORE | - |
hcfmusp.publisher.country | SINGAPORE | - |
hcfmusp.relation.reference | Almeida AS, 2014, PLOS ONE, V9 | - |
hcfmusp.relation.reference | Anderson L, 2016, J AM COLL CARDIOL, V67, P1, DOI 10.1016/j.jacc.2015.10.044 | - |
hcfmusp.relation.reference | Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1 | - |
hcfmusp.relation.reference | Barbosa VA, 2012, INT J CARDIOL, V157, P422, DOI 10.1016/j.ijcard.2012.03.153 | - |
hcfmusp.relation.reference | Barboza CA, 2013, EUR J APPL PHYSIOL, V113, P1137, DOI 10.1007/s00421-012-2533-3 | - |
hcfmusp.relation.reference | Bito V, 2010, CARDIOVASC RES, V86, P72, DOI 10.1093/cvr/cvp381 | - |
hcfmusp.relation.reference | Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008 | - |
hcfmusp.relation.reference | Casanova G., 2007, HIPERTENSAO, V10, P131 | - |
hcfmusp.relation.reference | Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097810 | - |
hcfmusp.relation.reference | Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789 | - |
hcfmusp.relation.reference | Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473 | - |
hcfmusp.relation.reference | Dayan A, 2005, ANN CLIN LAB SCI, V35, P73 | - |
hcfmusp.relation.reference | de Freitas VGG, 2016, SUPLEM REV SOC CARDI, V26, P21 | - |
hcfmusp.relation.reference | Dokken BB, 2008, DIABETES SPECTR, V21, P160, DOI 10.2337/DIASPECT.21.3.160 | - |
hcfmusp.relation.reference | Flores LJ, 2010, MENOPAUSE, V17, P712, DOI 10.1097/gme.0b013e3181cdebc9 | - |
hcfmusp.relation.reference | Frederico MJS, 2009, FREE RADICAL RES, V43, P957, DOI 10.1080/10715760903159154 | - |
hcfmusp.relation.reference | Freimann S, 2005, J AM COLL CARDIOL, V45, P931, DOI 10.1016/j.jacc.2004.11.052 | - |
hcfmusp.relation.reference | Grans CF, 2014, ARQ BRAS CARDIOL, V103, P60, DOI 10.5935/abc.20140093 | - |
hcfmusp.relation.reference | Hildreth KL, 2014, MENOPAUSE, V21, P624, DOI [10.1097/GME.0000000000000116, 10.1097/gme.0000000000000116] | - |
hcfmusp.relation.reference | Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335 | - |
hcfmusp.relation.reference | Jorge L, 2011, EUR HEART J, V32, P904, DOI 10.1093/eurheartj/ehq244 | - |
hcfmusp.relation.reference | Kraus WE, 2015, CIRCULATION, V131, P1932, DOI 10.1161/CIR.0000000000000203 | - |
hcfmusp.relation.reference | Kumar M, 2016, REGUL TOXICOL PHARM, V76, P221, DOI 10.1016/j.yrtph.2016.03.005 | - |
hcfmusp.relation.reference | La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.00000237565.12764.E1 | - |
hcfmusp.relation.reference | La Rovere MT, 1998, LANCET, V351, P478 | - |
hcfmusp.relation.reference | Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878 | - |
hcfmusp.relation.reference | Lisabeth L, 2012, LANCET NEUROL, V11, P82, DOI 10.1016/S1474-4422(11)70269-1 | - |
hcfmusp.relation.reference | Lobo HG, 2011, REV BRAS CIR CARDIOV, V26, P469, DOI 10.5935/1678-9741.20110024 | - |
hcfmusp.relation.reference | Bozi LHM, 2013, CLINICS, V68, P549, DOI 10.6061/clinics/2013(04)18 | - |
hcfmusp.relation.reference | McAloon CJ, 2016, INT J CARDIOL, V1, P56 | - |
hcfmusp.relation.reference | Melo SFS, 2014, CELL PHYSIOL BIOCHEM, V33, P657, DOI 10.1159/000358642 | - |
hcfmusp.relation.reference | Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x | - |
hcfmusp.relation.reference | Mostarda C, 2014, AM J TRANSL RES, V6, P320 | - |
hcfmusp.relation.reference | Nakamura K, 1998, CIRCULATION, V98, P794 | - |
hcfmusp.relation.reference | PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161 | - |
hcfmusp.relation.reference | Piepoli MF, 2016, EUR J PREV CARDIOL, V23, P1994, DOI 10.1177/2047487316663873 | - |
hcfmusp.relation.reference | Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3 | - |
hcfmusp.relation.reference | Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032 | - |
hcfmusp.relation.reference | Price KJ, 2016, EUR J PREV CARDIOL, V23, P1715, DOI 10.1177/2047487316657669 | - |
hcfmusp.relation.reference | Puhl SL, 2015, AM J PHYSIOL-HEART C, V309, pH345, DOI 10.1152/ajpheart.00683.2014 | - |
hcfmusp.relation.reference | Rodrigues B, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/702473 | - |
hcfmusp.relation.reference | Rodrigues B, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/207131 | - |
hcfmusp.relation.reference | Rodrigues B, 2013, J DIABETES COMPLICAT, V27, P16, DOI 10.1016/j.jdiacomp.2012.08.002 | - |
hcfmusp.relation.reference | Rodrigues B, 2012, J CARD FAIL, V18, P734, DOI 10.1016/j.cardfail.2012.07.006 | - |
hcfmusp.relation.reference | Rodrigues F, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-84 | - |
hcfmusp.relation.reference | Sutton MGS, 2000, CIRCULATION, V101, P2981 | - |
hcfmusp.relation.reference | Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9 | - |
hcfmusp.relation.reference | Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556 | - |
hcfmusp.relation.reference | Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073 | - |
hcfmusp.relation.reference | Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004 | - |
hcfmusp.relation.reference | Yengo CM, 2012, MED SCI SPORT EXER, V44, P1005, DOI 10.1249/MSS.0b013e318244bc8a | - |
hcfmusp.relation.reference | Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9 | - |
hcfmusp.relation.reference | Zanesco A, 2009, REV BRAS GINECOL OBS, V31, P254, DOI 10.1590/S0100-72032009000500009 | - |
hcfmusp.relation.reference | Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013 | - |
dc.description.index | MEDLINE | - |
dc.identifier.eissn | 2214-8019 | - |
hcfmusp.citation.scopus | 35 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/InCor Artigos e Materiais de Revistas Científicas - LIM/59 Artigos e Materiais de Revistas Científicas - ODS/02 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_MORAES-SILVA_Myocardial_Infarction_and_Exercise_Training_Evidence_from_Basic_2017.PDF Restricted Access | publishedVersion (English) | 346.42 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.